Skip to main content
BioVaxys Technology Corp. logo

BioVaxys Technology Corp. — Investor Relations & Filings

Ticker · BIOV LEI · 894500UD22QWRLZYJ229 CSE Professional, scientific and technical activities
Open in API
Filings indexed 270 across all filing types
Latest filing 2025-01-18 Regulatory Filings
Country CA Canada
Listing CSE BIOV

About BioVaxys Technology Corp.

https://biovaxys.com/

BioVaxys Technology Corp. is a clinical-stage biopharmaceutical company specializing in the development and out-licensing of novel immunotherapy assets. The core technology is the proprietary DPX™ platform, a unique lipid-in-oil formulation designed for sustained, targeted immune responses. DPX forces active uptake into immune cells and lymph nodes, avoiding systemic side effects common to conventional delivery methods. The platform is versatile, supporting peptides, proteins, mRNA, and small molecules, and is being applied across oncology, infectious disease, allergy, and autoimmune disorders. The lead clinical asset, Maveropepimut-S (MVP-S), has demonstrated promising Phase 2B results in recurrent ovarian cancer and relapsed/refractory Diffuse Large B-Cell Lymphoma (DLBCL). The company is also integrating Artificial Intelligence to enhance immunotherapeutic discovery.

Recent filings

Filing Released Lang Actions
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is the full text of Form 45-106F1 “Report of Exempt Distribution,” a Canadian securities regulatory filing detailing an exempt distribution of units and warrants and related fundraising information. It is not an earnings release, management discussion, or dividend notice, nor an investor presentation. It is not simply announcing an upcoming report (RPA); it is the actual regulatory report filed under National Instrument 45-106. It therefore falls under the catch-all category Regulatory Filings (RNS).
2025-01-18 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the closing of the third tranche of a non‐brokered private placement, detailing the number of units issued, pricing, warrants, use of proceeds, hold periods, and anticipated closing of the final tranche. This is a fundraising/capital structure update, not a full financial report or regulatory filing. Hence it falls under Capital/Financing Update (CAP).
2025-01-11 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a Canadian securities regulatory Form 45-106F1 “Report of Exempt Distribution,” a detailed statutory filing required under National Instrument 45-106. It is not an earnings release, management presentation, or investor presentation, nor does it announce a dividend, board change, or M&A. It is a mandatory regulatory disclosure form, falling into the general “Regulatory Filings” fallback category.
2025-01-02 English
Report of exempt distribution (45-106F1).pdf
Share Issue/Capital Change Classification · 1% confidence The document is Form 45-106F1 “Report of Exempt Distribution,” a mandatory Canadian regulatory filing reporting the issuance of new securities under an exempt distribution. It details the number, price, and terms of newly issued units and warrants. This is not a financial report (10-K/IR), dividend notice, or management discussion, but rather a direct report of a share issuance transaction. Therefore it falls under Share Issue/Capital Change (SHA).
2024-12-21 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the closing of the second tranche of a non-brokered private placement, detailing the issuance of units (common shares and warrants), the aggregate proceeds, use of proceeds, and related financing terms. This clearly represents a fundraising/financing activity update rather than a formal report, annual filing, or regulatory notice. Therefore, it falls under the “Capital/Financing Update” category.
2024-12-19 English
News release - English.pdf
M&A Activity Classification · 1% confidence The document is a press release announcing the final court order and expected closing of a corporate plan of arrangement (spin-out) of subsidiaries, which is a form of merger/acquisition or corporate restructuring transaction. It is not a routine financing update or mere publication notice, but an M&A-type transaction announcement.
2024-12-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.